Antipsychotic Drugs Market Research Report by Class (First Generation, Second Generation, and Third generation), by Application (Bipolar disorders, Dementia, and Schizophrenia), by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global

Antipsychotic Drugs Market Research Report by Class (First Generation, Second Generation, and Third generation), by Application (Bipolar disorders, Dementia, and Schizophrenia), by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026 - Cumulative Impact of COVID-19

The Global Antipsychotic Drugs Market size was estimated at USD 7,729.88 million in 2020 and expected to reach USD 8,308.75 million in 2021, at a CAGR 7.82% to reach USD 12,149.03 million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.


Market Segmentation & Coverage:

This research report categorizes the Antipsychotic Drugs to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Class, the market was studied across First Generation, Second Generation, and Third generation. The First Generation is further studied across Haldo and Navane. The Second Generation is further studied across Geodon, Invega, Latuda, Risperdal, Seroquel, and Zyprexa. The Third generation is further studied across Abilify.

Based on Application, the market was studied across Bipolar disorders, Dementia, Schizophrenia, and Unipolar Depression.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Antipsychotic Drugs Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Antipsychotic Drugs Market, including Alkermes PLC, Allergan PLC, AMBOSS GmbH, AstraZeneca PLC, Bristol-Myers Squibb Company, Daiichi Sankyo Co. Ltd., Dr. Reddy's Laboratories, Ltd., Eli Lilly & Co., F.Hoffmann-La Roche AG, Flagship Biotech International Pvt. Ltd, GlaxoSmithKline PLC, H. Lundbeck A/S, Karger AG, Luye Pharma Group, Merck & Co., Inc., Novartis AG, Otsuka Pharmaceutical Co. Ltd., Pfizer, Inc., Questex LLC, Sumitomo Dainippon Pharma Co., Ltd., Teva Pharmaceutical Industries, Ltd., The Medicines Co., and Vanda Pharmaceuticals Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Antipsychotic Drugs Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Antipsychotic Drugs Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Antipsychotic Drugs Market?
4. What is the competitive strategic window for opportunities in the Global Antipsychotic Drugs Market?
5. What are the technology trends and regulatory frameworks in the Global Antipsychotic Drugs Market?
6. What is the market share of the leading vendors in the Global Antipsychotic Drugs Market?
7. What modes and strategic moves are considered suitable for entering the Global Antipsychotic Drugs Market?


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
3.1. Introduction
4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.2.1. Increasing prevalence of psychosis and associated diseases
5.3. Restraints
5.3.1. Patent expiry of established brands
5.4. Opportunities
5.4.1. Increasing prevalence of psychosis and associated diseases
5.4.2. Enhancement in healthcare facilities coupled with government efforts to improve healthcare sector
5.5. Challenges
5.5.1. Negative impact on the patients such as insomnia, blurred vision, and dry mouth
5.5.2. Stringent regulatory framework and compliance
6. Antipsychotic Drugs Market, by Class
6.1. Introduction
6.2. First Generation
6.2.1. Haldo
6.2.2. Navane
6.3. Second Generation
6.3.1. Geodon
6.3.2. Invega
6.3.3. Latuda
6.3.4. Risperdal
6.3.5. Seroquel
6.3.6. Zyprexa
6.4. Third generation
6.4.1. Abilify
7. Antipsychotic Drugs Market, by Application
7.1. Introduction
7.2. Bipolar disorders
7.3. Dementia
7.4. Schizophrenia
7.5. Unipolar Depression
8. Americas Antipsychotic Drugs Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Antipsychotic Drugs Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
10. Europe, Middle East & Africa Antipsychotic Drugs Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. Alkermes PLC
12.2. Allergan PLC
12.3. AMBOSS GmbH
12.4. AstraZeneca PLC
12.5. Bristol-Myers Squibb Company
12.6. Daiichi Sankyo Co. Ltd.
12.7. Dr. Reddy's Laboratories, Ltd.
12.8. Eli Lilly & Co.
12.9. F.Hoffmann-La Roche AG
12.10. Flagship Biotech International Pvt. Ltd
12.11. GlaxoSmithKline PLC
12.12. H. Lundbeck A/S
12.13. Karger AG
12.14. Luye Pharma Group
12.15. Merck & Co., Inc.
12.16. Novartis AG
12.17. Otsuka Pharmaceutical Co. Ltd.
12.18. Pfizer, Inc.
12.19. Questex LLC
12.20. Sumitomo Dainippon Pharma Co., Ltd.
12.21. Teva Pharmaceutical Industries, Ltd.
12.22. The Medicines Co.
12.23. Vanda Pharmaceuticals Inc.
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 3. GLOBAL ANTIPSYCHOTIC DRUGS MARKET: MARKET DYNAMICS
FIGURE 4. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2020 VS 2026 (%)
FIGURE 5. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2020 VS 2026 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2026
FIGURE 7. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2026 (USD MILLION)
FIGURE 8. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 9. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY HALDO, 2018-2026 (USD MILLION)
FIGURE 10. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY HALDO, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 11. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY NAVANE, 2018-2026 (USD MILLION)
FIGURE 12. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY NAVANE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 13. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2026 (USD MILLION)
FIGURE 14. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 15. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEODON, 2018-2026 (USD MILLION)
FIGURE 16. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEODON, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 17. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INVEGA, 2018-2026 (USD MILLION)
FIGURE 18. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INVEGA, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 19. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY LATUDA, 2018-2026 (USD MILLION)
FIGURE 20. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY LATUDA, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 21. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY RISPERDAL, 2018-2026 (USD MILLION)
FIGURE 22. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY RISPERDAL, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 23. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SEROQUEL, 2018-2026 (USD MILLION)
FIGURE 24. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SEROQUEL, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 25. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY ZYPREXA, 2018-2026 (USD MILLION)
FIGURE 26. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY ZYPREXA, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 27. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2026 (USD MILLION)
FIGURE 28. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 29. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY ABILIFY, 2018-2026 (USD MILLION)
FIGURE 30. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY ABILIFY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 31. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 32. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
FIGURE 33. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2026
FIGURE 34. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY BIPOLAR DISORDERS, 2018-2026 (USD MILLION)
FIGURE 35. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY BIPOLAR DISORDERS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 36. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY DEMENTIA, 2018-2026 (USD MILLION)
FIGURE 37. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY DEMENTIA, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 38. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SCHIZOPHRENIA, 2018-2026 (USD MILLION)
FIGURE 39. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SCHIZOPHRENIA, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 40. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY UNIPOLAR DEPRESSION, 2018-2026 (USD MILLION)
FIGURE 41. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY UNIPOLAR DEPRESSION, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 42. AMERICAS ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 43. ARGENTINA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 44. BRAZIL ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 45. CANADA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 46. MEXICO ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 47. UNITED STATES ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 48. ASIA-PACIFIC ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 49. AUSTRALIA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 50. CHINA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 51. INDIA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 52. INDONESIA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 53. JAPAN ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 54. MALAYSIA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 55. PHILIPPINES ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 56. SINGAPORE ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 57. SOUTH KOREA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 58. TAIWAN ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 59. THAILAND ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 60. EUROPE, MIDDLE EAST & AFRICA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 61. FRANCE ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 62. GERMANY ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 63. ITALY ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 64. NETHERLANDS ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 65. QATAR ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 66. RUSSIA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 67. SAUDI ARABIA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 68. SOUTH AFRICA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 69. SPAIN ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 70. UNITED ARAB EMIRATES ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 71. UNITED KINGDOM ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 72. GLOBAL ANTIPSYCHOTIC DRUGS MARKET: FPNV POSITIONING MATRIX
FIGURE 73. GLOBAL ANTIPSYCHOTIC DRUGS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 74. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ANTIPSYCHOTIC DRUGS MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL ANTIPSYCHOTIC DRUGS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, BY REGION, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY HALDO, BY REGION, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY NAVANE, BY REGION, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, BY REGION, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEODON, BY REGION, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INVEGA, BY REGION, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY LATUDA, BY REGION, 2018-2026 (USD MILLION)
TABLE 12. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY RISPERDAL, BY REGION, 2018-2026 (USD MILLION)
TABLE 13. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SEROQUEL, BY REGION, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY ZYPREXA, BY REGION, 2018-2026 (USD MILLION)
TABLE 15. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, BY REGION, 2018-2026 (USD MILLION)
TABLE 16. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY ABILIFY, BY REGION, 2018-2026 (USD MILLION)
TABLE 17. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 18. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY BIPOLAR DISORDERS, BY REGION, 2018-2026 (USD MILLION)
TABLE 19. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY DEMENTIA, BY REGION, 2018-2026 (USD MILLION)
TABLE 20. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SCHIZOPHRENIA, BY REGION, 2018-2026 (USD MILLION)
TABLE 21. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY UNIPOLAR DEPRESSION, BY REGION, 2018-2026 (USD MILLION)
TABLE 22. AMERICAS ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 23. ARGENTINA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 24. BRAZIL ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 25. CANADA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 26. MEXICO ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 27. UNITED STATES ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 28. ASIA-PACIFIC ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 29. AUSTRALIA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 30. CHINA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 31. INDIA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 32. INDONESIA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 33. JAPAN ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 34. MALAYSIA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 35. PHILIPPINES ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 36. SINGAPORE ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 37. SOUTH KOREA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 38. TAIWAN ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 39. THAILAND ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 40. EUROPE, MIDDLE EAST & AFRICA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 41. FRANCE ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 42. GERMANY ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 43. ITALY ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 44. NETHERLANDS ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 45. QATAR ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 46. RUSSIA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 47. SAUDI ARABIA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 48. SOUTH AFRICA ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 49. SPAIN ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 50. UNITED ARAB EMIRATES ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 51. UNITED KINGDOM ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 52. GLOBAL ANTIPSYCHOTIC DRUGS MARKET: SCORES
TABLE 53. GLOBAL ANTIPSYCHOTIC DRUGS MARKET: BUSINESS STRATEGY
TABLE 54. GLOBAL ANTIPSYCHOTIC DRUGS MARKET: PRODUCT SATISFACTION
TABLE 55. GLOBAL ANTIPSYCHOTIC DRUGS MARKET: RANKING
TABLE 56. GLOBAL ANTIPSYCHOTIC DRUGS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 57. GLOBAL ANTIPSYCHOTIC DRUGS MARKET: MERGER & ACQUISITION
TABLE 58. GLOBAL ANTIPSYCHOTIC DRUGS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 59. GLOBAL ANTIPSYCHOTIC DRUGS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 60. GLOBAL ANTIPSYCHOTIC DRUGS MARKET: INVESTMENT & FUNDING
TABLE 61. GLOBAL ANTIPSYCHOTIC DRUGS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 62. GLOBAL ANTIPSYCHOTIC DRUGS MARKET: LICENSE & PRICING

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook